Products/Service

* Furosemide * Chlorpromazine hydrochloride * Mexiletine Hydrochloride * Benztropine Mesylate * Lorazepam

Clientele Type

USA based clienteles

Premises

manufacturing premise in Vadodara

Asking Price Includes

% of Equity or interest can be discussed

Reason

Expansion plans

Other Details

The company has been re-started in 2019. The company has set up its manufacturing facility for the production of API (Active Pharmaceuticals Ingredient) with a production capacity of 300 MT/Annum.
The promoters are looking for starting capital. Bank has sanctioned 60% of the amount needed and remaining INR 20-25 cr is to be raised through debt/equity funding.